Literature DB >> 33420488

Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression.

Sujun Chen1,2,3,4, Guanghui Zhu1,2,5,6, Yue Yang1, Fubo Wang1, Yu-Tian Xiao1, Na Zhang7, Xiaojie Bian8, Yasheng Zhu1, Yongwei Yu1, Fei Liu9, Keqin Dong1, Javier Mariscal10, Yin Liu11, Fraser Soares2, Helen Loo Yau2,3, Bo Zhang12, Weidong Chen12, Chao Wang12, Dai Chen12, Qinghua Guo12, Zhengfang Yi7, Mingyao Liu7, Michael Fraser2, Daniel D De Carvalho2,3, Paul C Boutros3,13,14,15,16,17, Dolores Di Vizio10,18,19,20, Zhou Jiang21, Theodorus van der Kwast2, Alejandro Berlin2,22, Song Wu5,6, Jianhua Wang23, Housheng Hansen He24,25, Shancheng Ren26.   

Abstract

Prostate cancer shows remarkable clinical heterogeneity, which manifests in spatial and clonal genomic diversity. By contrast, the transcriptomic heterogeneity of prostate tumours is poorly understood. Here we have profiled the transcriptomes of 36,424 single cells from 13 prostate tumours and identified the epithelial cells underlying disease aggressiveness. The tumour microenvironment (TME) showed activation of multiple progression-associated transcriptomic programs. Notably, we observed promiscuous KLK3 expression and validated the ability of cancer cells in altering T-cell transcriptomes. Profiling of a primary tumour and two matched lymph nodes provided evidence that KLK3 ectopic expression is associated with micrometastases. Close cell-cell communication exists among cells. We identified an endothelial subset harbouring active communication (activated endothelial cells, aECs) with tumour cells. Together with sequencing of an additional 11 samples, we showed that aECs are enriched in castration-resistant prostate cancer and promote cancer cell invasion. Finally, we created a user-friendly web interface for users to explore the sequenced data.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33420488     DOI: 10.1038/s41556-020-00613-6

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  67 in total

1.  Increasing incidence of metastatic prostate cancer in the United States (2004-2013).

Authors:  A B Weiner; R S Matulewicz; S E Eggener; E M Schaeffer
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-07-19       Impact factor: 5.554

2.  Widespread and Functional RNA Circularization in Localized Prostate Cancer.

Authors:  Sujun Chen; Vincent Huang; Xin Xu; Julie Livingstone; Fraser Soares; Jouhyun Jeon; Yong Zeng; Junjie Tony Hua; Jessica Petricca; Haiyang Guo; Miranda Wang; Fouad Yousif; Yuzhe Zhang; Nilgun Donmez; Musaddeque Ahmed; Stas Volik; Anna Lapuk; Melvin L K Chua; Lawrence E Heisler; Adrien Foucal; Natalie S Fox; Michael Fraser; Vinayak Bhandari; Yu-Jia Shiah; Jiansheng Guan; Jixi Li; Michèle Orain; Valérie Picard; Hélène Hovington; Alain Bergeron; Louis Lacombe; Yves Fradet; Bernard Têtu; Stanley Liu; Felix Feng; Xue Wu; Yang W Shao; Malgorzata A Komor; Cenk Sahinalp; Colin Collins; Youri Hoogstrate; Mark de Jong; Remond J A Fijneman; Teng Fei; Guido Jenster; Theodorus van der Kwast; Robert G Bristow; Paul C Boutros; Housheng Hansen He
Journal:  Cell       Date:  2019-02-07       Impact factor: 41.582

Review 3.  [Problems of age-dependent differences in digestion].

Authors:  F Dietze; G Brüschke
Journal:  Dtsch Gesundheitsw       Date:  1970-06-10

4.  Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy.

Authors:  Shuang G Zhao; S Laura Chang; Nicholas Erho; Menggang Yu; Jonathan Lehrer; Mohammed Alshalalfa; Corey Speers; Matthew R Cooperberg; Won Kim; Charles J Ryan; Robert B Den; Stephen J Freedland; Edwin Posadas; Howard Sandler; Eric A Klein; Peter Black; Roland Seiler; Scott A Tomlins; Arul M Chinnaiyan; Robert B Jenkins; Elai Davicioni; Ashley E Ross; Edward M Schaeffer; Paul L Nguyen; Peter R Carroll; R Jeffrey Karnes; Daniel E Spratt; Felix Y Feng
Journal:  JAMA Oncol       Date:  2017-12-01       Impact factor: 31.777

5.  Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome.

Authors:  Sungyong You; Beatrice S Knudsen; Nicholas Erho; Mohammed Alshalalfa; Mandeep Takhar; Hussam Al-Deen Ashab; Elai Davicioni; R Jeffrey Karnes; Eric A Klein; Robert B Den; Ashley E Ross; Edward M Schaeffer; Isla P Garraway; Jayoung Kim; Michael R Freeman
Journal:  Cancer Res       Date:  2016-06-14       Impact factor: 12.701

6.  Phenotype molding of stromal cells in the lung tumor microenvironment.

Authors:  Diether Lambrechts; Els Wauters; Bram Boeckx; Sara Aibar; David Nittner; Oliver Burton; Ayse Bassez; Herbert Decaluwé; Andreas Pircher; Kathleen Van den Eynde; Birgit Weynand; Erik Verbeken; Paul De Leyn; Adrian Liston; Johan Vansteenkiste; Peter Carmeliet; Stein Aerts; Bernard Thienpont
Journal:  Nat Med       Date:  2018-07-09       Impact factor: 53.440

7.  Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment.

Authors:  Elham Azizi; Ambrose J Carr; George Plitas; Andrew E Cornish; Catherine Konopacki; Sandhya Prabhakaran; Juozas Nainys; Kenmin Wu; Vaidotas Kiseliovas; Manu Setty; Kristy Choi; Rachel M Fromme; Phuong Dao; Peter T McKenney; Ruby C Wasti; Krishna Kadaveru; Linas Mazutis; Alexander Y Rudensky; Dana Pe'er
Journal:  Cell       Date:  2018-06-28       Impact factor: 41.582

8.  Analysis of Single-Cell RNA-Seq Identifies Cell-Cell Communication Associated with Tumor Characteristics.

Authors:  Manu P Kumar; Jinyan Du; Georgia Lagoudas; Yang Jiao; Andrew Sawyer; Daryl C Drummond; Douglas A Lauffenburger; Andreas Raue
Journal:  Cell Rep       Date:  2018-11-06       Impact factor: 9.423

9.  Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.

Authors:  J Ferlay; M Colombet; I Soerjomataram; C Mathers; D M Parkin; M Piñeros; A Znaor; F Bray
Journal:  Int J Cancer       Date:  2018-12-06       Impact factor: 7.396

10.  SCENIC: single-cell regulatory network inference and clustering.

Authors:  Sara Aibar; Carmen Bravo González-Blas; Thomas Moerman; Vân Anh Huynh-Thu; Hana Imrichova; Gert Hulselmans; Florian Rambow; Jean-Christophe Marine; Pierre Geurts; Jan Aerts; Joost van den Oord; Zeynep Kalender Atak; Jasper Wouters; Stein Aerts
Journal:  Nat Methods       Date:  2017-10-09       Impact factor: 28.547

View more
  55 in total

1.  Identification of prostate cancer subtypes based on immune signature scores in bulk and single-cell transcriptomes.

Authors:  Canping Chen; Jiangti Luo; Xiaosheng Wang
Journal:  Med Oncol       Date:  2022-06-18       Impact factor: 3.064

2.  Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment.

Authors:  Youmna Kfoury; Ninib Baryawno; Nicolas Severe; Shenglin Mei; Karin Gustafsson; Taghreed Hirz; Thomas Brouse; Elizabeth W Scadden; Anna A Igolkina; Konstantinos Kokkaliaris; Bryan D Choi; Nikolas Barkas; Mark A Randolph; John H Shin; Philip J Saylor; David T Scadden; David B Sykes; Peter V Kharchenko
Journal:  Cancer Cell       Date:  2021-10-15       Impact factor: 31.743

Review 3.  Fibroblast heterogeneity in prostate carcinogenesis.

Authors:  Sathyavathi ChallaSivaKanaka; Renee E Vickman; Mamatha Kakarla; Simon W Hayward; Omar E Franco
Journal:  Cancer Lett       Date:  2021-10-29       Impact factor: 8.679

Review 4.  Clinical and therapeutic relevance of cancer-associated fibroblasts.

Authors:  Yang Chen; Kathleen M McAndrews; Raghu Kalluri
Journal:  Nat Rev Clin Oncol       Date:  2021-09-06       Impact factor: 66.675

Review 5.  Cancer-associated fibroblasts in the single-cell era.

Authors:  Dor Lavie; Aviad Ben-Shmuel; Neta Erez; Ruth Scherz-Shouval
Journal:  Nat Cancer       Date:  2022-07-26

6.  Tissue-resident glial cells associate with tumoral vasculature and promote cancer progression.

Authors:  Beatriz G S Rocha; Caroline C Picoli; Bryan O P Gonçalves; Walison N Silva; Alinne C Costa; Michele M Moraes; Pedro A C Costa; Gabryella S P Santos; Milla R Almeida; Luciana M Silva; Youvika Singh; Marcelo Falchetti; Gabriela D A Guardia; Pedro P G Guimarães; Remo C Russo; Rodrigo R Resende; Mauro C X Pinto; Jaime H Amorim; Vasco A C Azevedo; Alexandre Kanashiro; Helder I Nakaya; Edroaldo L Rocha; Pedro A F Galante; Akiva Mintz; Paul S Frenette; Alexander Birbrair
Journal:  Angiogenesis       Date:  2022-10-01       Impact factor: 10.658

Review 7.  Prostate Cancer Epigenetic Plasticity and Enhancer Heterogeneity: Molecular Causes, Consequences and Clinical Implications.

Authors:  Jeroen Kneppers; Andries M Bergman; Wilbert Zwart
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 8.  Overcoming Immune Resistance With Radiation Therapy in Prostate Cancer.

Authors:  Arthur Mulvey; Emilien Muggeo-Bertin; Dominik R Berthold; Fernanda G Herrera
Journal:  Front Immunol       Date:  2022-04-28       Impact factor: 8.786

Review 9.  Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer.

Authors:  Eshwari Dathathri; Khrystany T Isebia; Fikri Abali; Martijn P Lolkema; John W M Martens; Leon W M M Terstappen; Ruchi Bansal
Journal:  Front Oncol       Date:  2022-05-20       Impact factor: 5.738

10.  Comprehensive assessment of cellular senescence in the tumor microenvironment.

Authors:  Xiaoman Wang; Lifei Ma; Xiaoya Pei; Heping Wang; Xiaoqiang Tang; Jian-Fei Pei; Yang-Nan Ding; Siyao Qu; Zi-Yu Wei; Hui-Yu Wang; Xiaoyue Wang; Gong-Hong Wei; De-Pei Liu; Hou-Zao Chen
Journal:  Brief Bioinform       Date:  2022-05-13       Impact factor: 13.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.